United States — Center for Drug Evaluation and Research
Tracked across 1 events · 7 articles · First seen Jun 12, 2026 · Last active Jun 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: The United States — Center for Drug Evaluation and Research provided positive pre-submission regulatory feedback for NCX 470, which is crucial for the drug's approval process in China.
Jun 18, 2026 · 7 articles
NEWSDESK
Track United States — Center for Drug Evaluation and Research live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard